USPTO serial 98886873
PROPHECG
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- GULIANO, ROBERT N
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PROPHECG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John M. Kim
John M. Kim IPLA, LLP4445 Eastgate MallSuite 200San Diego, CA 92121Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Chemical, biochemical, and chemical analysis and research, namely, performing pharmaceutical screening assays for others; Drug screening for scientific research purposes, namely, development and testing, screening and analysis of pharmaceutical, chemical and biological substances for use in drug discovery research; Pharmaceutical research services; Pharmaceutical product evaluation; Providing medical and scientific research information in the field of pharmaceuticals; Consulting services in the field of pharmaceutical research; Conducting early evaluations in the field of new pharmaceuticals; Platform as a service (PAAS) services featuring computer software platforms for analyzing and reporting pharmaceutical drug screening and clinical research data in the field of pharmaceutical drugs; Software as a service (SAAS) services featuring software for analyzing and reporting pharmaceutical drug screening and clinical research data in the field of pharmaceutical drugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Clinical trial scientific research consulting services; Product research and development services for others in the fields of pharmaceuticals, biopharmaceuticals, health care products, and medical products; Product development consulting in the fields of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 30, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 30, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 30, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 30, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 29, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 12, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2024 | NWAP | NEW APPLICATION ENTERED | — |